Unravelling the Liver–Heart Disease Connection

A staggering one-third of the global population may harbour metabolic dysfunction associated fatty liver disease (MAFLD). This burgeoning, obesity-related health crisis is projected to escalate, with obesity rates expected to jump from 15% in 2023 to ~25% by 2035. Metadvice stands at the forefront of this challenge, leveraging AI to empower clinicians in managing the complex web of chronic diseases, particularly where metabolic and cardiovascular disorders intersect. In this blog, we draw on new evidence to explore how Metadvice technology can address this growing disease area.

EASD CGM Abstract

Abstract submitted for the 59th meeting the European Association for the Study of Diabetes, EASD, Hamburg, October 2–6, 2023 Glucose-Insulin modelling of DM2 patients with CGM monitoring under various therapies David Herzig1, Lia Bally1, Thomas Castiglione2,3, Philippine Des Courtils2,3, André Jaun2 1 UDEM, Inselspital, Freiburgstrasse 2, 3010 Bern, Switzerland 2 Metadvice, Route Cantonale 109, 1025…

EASD AI Abstract

Combining clinical guidelines with continuous learning from real world evidence data has the potential to effectively implement precision medicine by clinicians caring for people with diabetes. Such AI-driven platforms that integrate data from electronic health records are available and are readily extendable to include data from wearable technologies.